Smt. Kiran Mazumdar-Shaw the pioneering entrepreneur and the founder and chairperson of Biocon Limited, India’s leading biopharmaceutical company has grown to become a global leader in the production of affordable medicines, including insulin and cancer treatments. In 2024, Biocon's revenue surpassed $2 billion, with a significant portion coming from its biosimilars portfolio, which includes treatments for cancers, autoimmune diseases, and diabetes. Mazumdar-Shaw’s innovative work in biotechnology has played a crucial role in shaping India’s healthcare landscape.